This topic contains a solution. Click here to go to the answer

Author Question: The blocks of code that application software needs to interact with the CPU is called: a. ... (Read 84 times)

jayhills49

  • Hero Member
  • *****
  • Posts: 559
The blocks of code that application software needs to interact with the CPU is called:
 
  a. Automatic Programming Interface.
  b. Automatic Program Instruction.
  c. Application Programming Interface.
  d. Application Program Instruction.

Question 2

Match each of the following steps of SDLC development to its position in the development process.
 
  I. development
  II. design
  III. analysis
  IV. testing and installation
  V. problem/opportunity identification
 
  A. first step
  B. second step
  C. third step
  D. fourth step
  E. fifth step



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Anna

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

C

Answer to Question 2

D, C, B, E, A




jayhills49

  • Member
  • Posts: 559
Reply 2 on: Aug 29, 2018
YES! Correct, THANKS for helping me on my review


Dominic

  • Member
  • Posts: 328
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Atropine was named after the Greek goddess Atropos, the oldest and ugliest of the three sisters known as the Fates, who controlled the destiny of men.

Did you know?

According to animal studies, the typical American diet is damaging to the liver and may result in allergies, low energy, digestive problems, and a lack of ability to detoxify harmful substances.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library